FDA Inspection 717132 — Delaware Institute for Reproductive Medicine, P.A

Delaware Institute for Reproductive Medicine, P.A — FEI 3003939643

The FDA completed an inspection of Delaware Institute for Reproductive Medicine, P.A on March 31, 2011 in Newark, DE. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 31, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Newark, DE (United States)

Citations

IDCFRDescription
1222121 CFR 1271.47(a)Procedures for all other requirements